Skip to main content
Clinical Trials/CTRI/2024/11/076696
CTRI/2024/11/076696
Not yet recruiting
Not Applicable

Efficacy of injectable platelet rich fibrin in immediate implant placement sites: A randomized controlled trial

Subhashini Balaguru1 site in 1 country20 target enrollmentStarted: November 30, 2024Last updated:

Overview

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Subhashini Balaguru
Enrollment
20
Locations
1
Primary Endpoint
thickness of gingiva

Overview

Brief Summary

purpose of the study is to access the efficacy of injectable platelet rich fibrin in immediate implant placement sites

Brief procedure

Atraumatic tooth extraction will be performed under local anesthesia

Extracted Socket will be assessed for Implant placement

The subjects who fulfill the inclusion criteria will be randomly assigned into following 2 groups using computer generated randomization

GROUP 1 (control group) 10 sites were treated with immediate implant placement with bone graft

GROUP 2(test group) 10 sites were treated with immediate implant placement with injectable platelet rich fibrin mixed with bone graft

The preparation of injectable platelet rich fibrin for the test group will be done by drawing 8 ml intravenous blood from the patient and collected into disposable plastic test tubes

As per Choukroun standard protocol centrifugation at 700rpm for 3min will be done

injectable platelet rich fibrin was created at upper level

It will be used along with DBM for test group

Both the groups will be assessed for clinical parameters

gingival biotype

peri implant probing depth and

radiographic parameters

marginal bone loss

peri implant radiolucency at baseline 1 4and 6months follow up

Study Design

Study Type
Interventional
Allocation
Randomized
Masking
Outcome Assessor Blinded

Eligibility Criteria

Ages
18.00 Year(s) to 65.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Age 18 to 65 years Good oral hygiene No acute infection Root fractures Grossly decayed roots Root resorptions Elians socket classification type I and II ASA PS I and II.

Exclusion Criteria

  • Smokers and alcoholics Pregnant and lactating women Presence of active infection Any periapical pathology Elians socket type III ASA PS III and above.

Outcomes

Primary Outcomes

thickness of gingiva

Time Frame: 6 months

peri-implant probing depth

Time Frame: 6 months

peri-implant radiolucency

Time Frame: 6 months

marginal bone level

Time Frame: 6 months

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Subhashini Balaguru
Sponsor Class
Other [self]
Responsible Party
Principal Investigator
Principal Investigator

Subhashini Balaguru

SRM kattankulathur dental college

Study Sites (1)

Loading locations...

Similar Trials